Similar articles

• [Combination chemotherapy with total or subtotal lymphatic irradiation in the treatment of lymphogranulomatosis, stage IIIA or IIIB (based on five- and ten-year results)].

  Kanaev SV, Gershanovich ML, Malinin AP. Kanaev SV, et al. Vopr Onkol. 1997;43(1):32-8. Vopr Onkol. 1997. PMID: 9133084 Russian.
• Current role and future developments of radiotherapy in early-stage favourable Hodgkin's lymphoma.

  Eich HT, Müller RP. Eich HT, et al. Strahlenther Onkol. 2007 Dec;183 Spec No 2:16-8. doi: 10.1007/s00066-007-2007-4. Strahlenther Onkol. 2007. PMID: 18167000 No abstract available.
• [New prognostic factors in the treatment of patients with stage-III Hodgkin's disease].

  Girshovich MM, Kanaev SV, Pozharisskiĭ KM, Golovanov SG, Barbashov AI. Girshovich MM, et al. Vopr Onkol. 2010;56(4):424-9. Vopr Onkol. 2010. PMID: 20968021 Russian.
• [Primary treatment of early stage Hodgkin's disease].

  Molnár Z, Esik O, Illés A. Molnár Z, et al. Orv Hetil. 2005 Jan 9;146(2):57-61. Orv Hetil. 2005. PMID: 15724953 Review. Hungarian.
• The role of radiation in the management of Hodgkin's disease: an update.

  Mendenhall NP. Mendenhall NP. Cancer Invest. 1999;17(1):47-55. Cancer Invest. 1999. PMID: 10999049 Review.